iShares Neuroscience and Healthcare ETF (IBRN)

Assets	$3.48M
Expense Ratio	0.47%
PE Ratio	16.44
Shares Out	150,000
Dividend (ttm)	$0.10
Dividend Yield	0.42%
Ex-Dividend Date	Dec 17, 2024
Payout Ratio	6.82%
1-Year Return	-0.37%

Volume	646
Open	24.29
Previous Close	23.70
Day's Range	24.13 - 24.36
52-Week Low	17.86
52-Week High	28.74
Beta	0.70
Holdings	63
Inception Date	Aug 24, 2022

About IBRN

Fund Home Page

The iShares Neuroscience and Healthcare ETF (IBRN) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a market cap-weighted index that provides global equity exposure to companies that are positioned to benefit from neuroscience advancements. The index may hold securities from large- to small-cap. IBRN was launched on Aug 24, 2022 and is issued by BlackRock.

• Asset Class: Equity
• Category: Health
• Region: Global
• Stock Exchange: NYSEARCA
• Ticker Symbol: IBRN
• ETF Provider: BlackRock
• Index Tracked: NYSE FactSet Global Neuro Biopharma and MedTech Index

Top 10 Holdings

41.98% of assets

Name	Symbol	Weight
Supernus Pharmaceuticals, Inc.	SUPN	4.95%
ACADIA Pharmaceuticals Inc.	ACAD	4.68%
Xenon Pharmaceuticals Inc.	XENE	4.60%
argenx SE	ARGX	4.40%
SK Biopharmaceuticals Co., Ltd.	326030	4.32%
Neurocrine Biosciences, Inc.	NBIX	4.15%
Biogen Inc.	BIIB	3.92%
Scholar Rock Holding Corporation	SRRK	3.81%
Denali Therapeutics Inc.	DNLI	3.63%
PTC Therapeutics, Inc.	PTCT	3.52%

Dividends

Ex-Dividend	Amount	Pay Date
Dec 17, 2024	$0.10114	Dec 20, 2024
Dec 20, 2023	$0.0063	Dec 27, 2023
Jun 7, 2023	$0.00824	Jun 13, 2023